All In Biotech

Drug Trial Radar · NCT05681351

CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG)

An Open-Label Extension Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Patients With Severe Hypertriglyceridemia (SHTG)

Last checked: Nov 20, 2026Latest source record: Dec 1, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

885

Actual

Start

Dec 13, 2022

Primary completion

Mar 2027

Study completion Mar 2027

Sponsor

Lead sponsor
Ionis Pharmaceuticals, Inc.Ionis Pharmaceuticals (IONS)
Sponsor type
Industry
First posted
Jan 12, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety and tolerability of olezarsen in participants with SHTG.

Conditions

  • Severe Hypertriglyceridemia

Interventions

  • OlezarsenDrug

    Administered as SC injection.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of Participants With Change in Clinical Laboratory Values From Baseline to Week 53, From Baseline to Week 105, and From Baseline to Week 157Time frame: Baseline up to Week 157
  2. Proportion of Participants Who Experience Adverse Events (AEs)Time frame: Baseline up to Week 157
  3. Proportion of Participants Who Use Concomitant MedicationsTime frame: Baseline up to Week 157

Locations

262 sites in 33 countries. Site status is shown where the registry gives one.

  • LA Universal Research Center, Inc.

    Los Angeles, California

  • University of California, San Diego (UCSD)

    San Diego, California

  • Metabolic Institute of America

    Tarzana, California

  • Excel Medical Clinical Trials

    Boca Raton, Florida

  • Finlay Medical Research

    Greenacres City, Florida

  • Columbus Clinical Services, LLC

    Miami, Florida

  • Finlay Medical Research

    Miami, Florida

  • Innovia Research Center, Inc.

    Miramar, Florida

  • Harmony Clinical Research, Inc.

    North Miami Beach, Florida

  • R & B Medical Center LLC

    Tampa, Florida

  • VICIS Clinical Research

    Tampa, Florida

  • JSV Clinical Research Study, Inc.

    Tampa, Florida

  • Bayside Clinical Research

    Trinity, Florida

  • Centricity Research

    Columbus, Georgia

  • IACT Health

    Columbus, Georgia

  • Affinity Health

    Oak Brook, Illinois

  • St. Vincent Medical Group, Inc.

    Carmel, Indiana

  • University of Kansas Medical Center (KUMC)

    Kansas City, Kansas

  • The Research Group of Lexington, LLC

    Lexington, Kentucky

  • Louisville Metabolic and Atherosclerosis Research Center (L-MARC)

    Louisville, Kentucky

  • Grace Research, LLC

    Bossier City, Louisiana

  • University of Maryland School of Medicine

    Baltimore, Maryland

  • IRC Clinics

    Towson, Maryland

  • Massachusetts General Hospital Heart Center

    Boston, Massachusetts

  • University of Michigan- Endocrinology & Metabolism

    Ann Arbor, Michigan

  • Aa Mrc, Llc

    Flint, Michigan

  • Washington School of Medicine

    St Louis, Missouri

  • Bryan Medical Center

    Lincoln, Nebraska

  • Palm Research Center, Inc.

    Las Vegas, Nevada

  • Hudson County Clinical Trials Research Center

    Union City, New Jersey

  • Modern Medical

    Brooklyn, New York

  • NYU Langone Health

    Mineola, New York

  • Langone Medical Center

    New York, New York

  • Vagelos College of Physicians and Surgeons of Columbia University

    New York, New York

  • Orchard Park Family Practice

    Orchard Park, New York

  • The Presbyterian Hospital DBA Novant Health Heart and Vascular Institute

    Charlotte, North Carolina

  • Kenneth Hilty

    Greensboro, North Carolina

  • Clinical Trials of America, LLC

    Lenoir, North Carolina

  • Lexington

    Winston-Salem, North Carolina

  • The Ohio State University

    Columbus, Ohio

Showing 40 of 262 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.